Treatment of shizophrenic patients and rTMS.

Author: BrunelinJerome, HaesebaertF, PouletEmmanuel, SaoudM, Suaud-ChagnyM F

Paper Details 
Original Abstract of the Article :
schizophrenia (SCH) is a heterogeneous syndrome characterized by positive and negative symptoms. Despite appropriate medication, about 1/4 of patients suffer for refractory positive and/or negative symptoms, which are associated with functional handicap, increase of duration and of the number of hos...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/21057425

データ提供:米国国立医学図書館(NLM)

Schizophrenia: A Desert of Disrupted Brain Activity

Schizophrenia, a complex mental illness that affects how people think, feel, and behave, is like a vast desert landscape where brain activity becomes disrupted. This research explores the potential of repetitive transcranial magnetic stimulation (rTMS) as a treatment for drug-resistant schizophrenia symptoms. The researchers investigate the efficacy of rTMS in targeting specific brain regions associated with auditory hallucinations and negative symptoms.

Finding a Path to Relief

The study suggests that rTMS may offer a promising treatment option for drug-resistant schizophrenia symptoms. This finding is like discovering a hidden oasis in a desert, providing a source of relief and hope for individuals struggling with this challenging condition.

Navigating the Desert of Mental Illness

Schizophrenia can be a debilitating condition, but this research offers hope for new treatment options. Like a camel traversing a desert, it is essential to find the right combination of strategies to manage symptoms effectively.

Dr. Camel's Conclusion

This research highlights the potential of rTMS as a treatment for drug-resistant schizophrenia symptoms. Like a camel discovering a new oasis in a desert, this research offers hope for individuals seeking relief from the challenges of schizophrenia. Remember, like a vast and unforgiving desert, schizophrenia requires a multi-faceted approach to find the right path to recovery.

Date :
  1. Date Completed 2011-03-18
  2. Date Revised 2018-12-01
Further Info :

Pubmed ID

21057425

DOI: Digital Object Identifier

21057425

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.